Por favor, use este identificador para citar o enlazar este ítem:
https://hdl.handle.net/10495/34257
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Vásquez Duque, Gloria María | - |
dc.contributor.author | Herrera Uribe, Sebastián | - |
dc.date.accessioned | 2023-03-27T19:49:45Z | - |
dc.date.available | 2023-03-27T19:49:45Z | - |
dc.date.issued | 2014 | - |
dc.identifier.issn | 1740-2557 | - |
dc.identifier.uri | https://hdl.handle.net/10495/34257 | - |
dc.description.abstract | ABSTRACT: Protein kinases have multiple roles in cell biology, many of which are deeply involved in inflammation and immunity. There are currently many treatment options for patients with autoimmune disease, but none that is completely effective. Protein kinase inhibitors are becoming one of the most promising therapeutic groups, not only for the treatment of disease, but for further developing our understanding of different pathologies. The purpose of this paper is to give an introduction to both protein kinases and their inhibitors, with their implications in the management of autoimmune diseases. | spa |
dc.format.extent | 15 | spa |
dc.format.mimetype | application/pdf | spa |
dc.language.iso | eng | spa |
dc.publisher | BioMed Central | spa |
dc.type.hasversion | info:eu-repo/semantics/publishedVersion | spa |
dc.rights | info:eu-repo/semantics/openAccess | spa |
dc.rights.uri | http://creativecommons.org/licenses/by/2.5/co/ | * |
dc.title | Protein Kinase Inhibitors in Rheumatology | spa |
dc.type | info:eu-repo/semantics/article | spa |
dc.publisher.group | Grupo de Reumatología Universidad de Antioquia -GRUA- | spa |
dc.identifier.doi | 10.12970/2310-9874.2014.02.01.4 | - |
oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 | spa |
dc.rights.accessrights | http://purl.org/coar/access_right/c_abf2 | spa |
oaire.citationtitle | Journal of Autoimmune Diseases | spa |
oaire.citationstartpage | 13 | spa |
oaire.citationendpage | 27 | spa |
oaire.citationvolume | 2 | spa |
thesis.degree.discipline | sin facultad - programa | spa |
dc.rights.creativecommons | https://creativecommons.org/licenses/by/4.0/ | spa |
dc.publisher.place | Londres, Inglaterra | spa |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | spa |
dc.type.redcol | http://purl.org/redcol/resource_type/CJournalArticle | spa |
dc.type.local | Artículo de revista | spa |
dc.subject.decs | Lupus Erythematosus, Systemic | - |
dc.subject.decs | Lupus Eritematoso Sistémico | - |
dc.subject.decs | Protein Kinases | - |
dc.subject.decs | Proteínas Quinasas | - |
dc.subject.decs | Phosphotransferases | - |
dc.subject.decs | Fosfotransferasas | - |
dc.subject.decs | Janus Kinase 3 | - |
dc.subject.decs | Janus Quinasa 3 | - |
dc.subject.decs | Autoimmune Diseases | - |
dc.subject.decs | Enfermedades Autoinmunes | - |
dc.subject.decs | Rheumatology | - |
dc.subject.decs | Reumatología | - |
dc.subject.decs | Cyclin-Dependent Kinase Inhibitor Proteins | - |
dc.subject.decs | Proteínas Inhibidoras de las Quinasas Dependientes de la Ciclina | - |
dc.identifier.url | https://synergypublishers.com/downloads/jadrv2n1a4/ | spa |
dc.description.researchgroupid | COL0010959 | spa |
dc.relation.ispartofjournalabbrev | J. Autoimmune Dis. | spa |
Aparece en las colecciones: | Artículos de Revista en Ciencias Médicas |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
VasquezGloria_2014_ProteinKinaseRheumatology.pdf | Artículo de revista | 1.37 MB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons